Citi raised the firm’s price target on Regeneron (REGN) to $700 from $660 and keeps a Buy rating on the shares. The company reported a strong Q3 and the stock’s risk/reward remains attractive given Regeneron’s pipeline potential, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on REGN:
- Regeneron price target raised to $767 from $756 at Morgan Stanley
- Midday Fly By: OpenAI signs new Microsoft deal, PayPal reports Q3 beat
- Early notable gainers among liquid option names on October 28th
- Morning Movers: UPS and PayPal jump following quarterly reports
- Regeneron reports Q3 non-GAAP EPS $11.83, consensus $9.64